Literature DB >> 27894567

Proportion of selected congenital heart defects attributable to recognized risk factors.

Regina M Simeone1, Sarah C Tinker2, Suzanne M Gilboa2, A J Agopian3, Matthew E Oster4, Owen J Devine5, Margaret A Honein2.   

Abstract

PURPOSE: To assess the contribution of multiple risk factors for two congenital heart defects-hypoplastic left heart syndrome (HLHS) and tetralogy of Fallot (TOF).
METHODS: We used data from the National Birth Defects Prevention Study (1997-2011) to estimate average adjusted population attributable fractions for several recognized risk factors, including maternal prepregnancy overweight-obesity, pregestational diabetes, age, and infant sex.
RESULTS: There were 594 cases of isolated simple HLHS, 971 cases of isolated simple TOF, and 11,829 controls in the analysis. Overall, 57.0% of HLHS cases and 37.0% of TOF cases were estimated to be attributable to risk factors included in our model. Among modifiable HLHS risk factors, maternal prepregnancy overweight-obesity accounted for the largest proportion of cases (6.5%). Among modifiable TOF risk factors, maternal prepregnancy overweight-obesity and maternal age of 35 years or older accounted for the largest proportions of cases (8.3% and 4.3%, respectively).
CONCLUSIONS: Approximately half of HLHS cases and one-third of TOF cases were estimated to be attributable to risk factors included in our models. Interventions targeting factors that can be modified may help reduce the risk of HLHS and TOF development. Additional research into the etiology of HLHS and TOF may reveal other modifiable risk factors that might contribute to primary prevention efforts. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart defects, congenital; Hypoplastic left heart syndrome; Population attributable fraction; Tetralogy of Fallot

Mesh:

Year:  2016        PMID: 27894567      PMCID: PMC5215098          DOI: 10.1016/j.annepidem.2016.10.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  72 in total

1.  First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Authors:  Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

2.  Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.

Authors:  Krista S Crider; Mario A Cleves; Jennita Reefhuis; Robert J Berry; Charlotte A Hobbs; Dale J Hu
Journal:  Arch Pediatr Adolesc Med       Date:  2009-11

3.  Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship.

Authors:  Suzanne R Block; Sharon M Watkins; Jason L Salemi; Rachel Rutkowski; Jean Paul Tanner; Jane A Correia; Russell S Kirby
Journal:  Paediatr Perinat Epidemiol       Date:  2013-10-10       Impact factor: 3.980

4.  Familial congenital heart disease: data collection and preliminary analysis.

Authors:  Xike Wang; Jing Wang; Pengjun Zhao; Ying Guo; Lanping Wu; Jing Sun; Kun Sun
Journal:  Cardiol Young       Date:  2012-10-01       Impact factor: 1.093

5.  Maternal obesity and congenital heart defects: a population-based study.

Authors:  James L Mills; James Troendle; Mary R Conley; Tonia Carter; Charlotte M Druschel
Journal:  Am J Clin Nutr       Date:  2010-04-07       Impact factor: 7.045

6.  Sex and congenital malformations: an international perspective.

Authors:  Alessandra Lisi; Lorenzo D Botto; Monica Rittler; Eduardo Castilla; Sebastiano Bianca; Fabrizio Bianchi; Beverley Botting; Hermien De Walle; J David Erickson; Miriam Gatt; Catherine De Vigan; Lorentz Irgens; William Johnson; Paul Lancaster; Paul Merlob; Osvaldo M Mutchinick; Annukka Ritvanen; Elisabeth Robert; Gioacchino Scarano; Claude Stoll; Pierpaolo Mastroiacovo
Journal:  Am J Med Genet A       Date:  2005-04-01       Impact factor: 2.802

7.  Use of oral contraceptives in pregnancy and major structural birth defects in offspring.

Authors:  Dorothy Kim Waller; Michael Shayne Gallaway; Lockwood G Taylor; Tunu A Ramadhani; Mark A Canfield; Angela Scheuerle; Sonia Hernández-Diaz; Carol Louik; Adolfo Correa
Journal:  Epidemiology       Date:  2010-03       Impact factor: 4.822

8.  Association between prepregnancy body mass index and congenital heart defects.

Authors:  Suzanne M Gilboa; Adolfo Correa; Lorenzo D Botto; Sonja A Rasmussen; D Kim Waller; Charlotte A Hobbs; Mario A Cleves; Tiffany J Riehle-Colarusso
Journal:  Am J Obstet Gynecol       Date:  2009-10-01       Impact factor: 8.661

9.  Congenital heart defects after maternal fever.

Authors:  Lorenzo D Botto; Janice D Panichello; Marilyn L Browne; Sergey Krikov; Marcia L Feldkamp; Edward Lammer; Gary M Shaw
Journal:  Am J Obstet Gynecol       Date:  2013-11-01       Impact factor: 8.661

10.  An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors.

Authors:  Simon Rückinger; Rüdiger von Kries; André Michael Toschke
Journal:  BMC Med Res Methodol       Date:  2009-01-23       Impact factor: 4.615

View more
  15 in total

1.  Genetic Testing and Pregnancy Outcome Analysis of 362 Fetuses with Congenital Heart Disease Identified by Prenatal Ultrasound.

Authors:  Shiyu Luo; Dahua Meng; Qifei Li; Xuehua Hu; Yuhua Chen; Chun He; Bobo Xie; Shangyang She; Yingfeng Li; Chunyun Fu
Journal:  Arq Bras Cardiol       Date:  2018-08-20       Impact factor: 2.000

2.  [Risk factors for congenital heart disease in Chinese neonates: a Meta analysis].

Authors:  Yi Liu; Bei Zhu; Lin Zhuo; Ming-Yu He; Yang Xu; Tong-Tong Wang; Qing-Qing Cai; Bin Hu; Ji-Cheng Xu; Wen-Hui Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

3.  Minority and low-income patients are less likely to have a scale for self-weighing in their home: A survey in primary care.

Authors:  Carolyn T Bramante; Grace Lee; Safira S Amsili; Jennifer A Linde; Sean M Phelan; Lawrence J Appel; Wendy L Bennett; Jeanne M Clark; Kimberly A Gudzune
Journal:  Clin Obes       Date:  2020-05-07

4.  Understanding Primary Care Patients' Self-weighing Habits: Cohort Analysis from the PaTH Clinical Data Research Network.

Authors:  Carolyn T Bramante; Kathleen M McTigue; Harold P Lehmann; Jeanne M Clark; Scott Rothenberger; Jennifer Kraschnewski; Michelle R Lent; Sharon J Herring; Molly B Conroy; Jody McCullough; Wendy L Bennett
Journal:  J Gen Intern Med       Date:  2019-07-16       Impact factor: 5.128

Review 5.  Genetics and Genomics of Congenital Heart Disease.

Authors:  Samir Zaidi; Martina Brueckner
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

Review 6.  Impact of maternal hyperglycemia on cardiac development: Insights from animal models.

Authors:  Talita Z Choudhury; Uddalak Majumdar; Madhumita Basu; Vidu Garg
Journal:  Genesis       Date:  2021-09-09       Impact factor: 2.487

7.  Genome-Wide De Novo Variants in Congenital Heart Disease Are Not Associated With Maternal Diabetes or Obesity.

Authors:  J G Seidman; Christine E Seidman; Sarah U Morton; Alexandre C Pereira; Daniel Quiat; Felix Richter; Alexander Kitaygorodsky; Jacob Hagen; Daniel Bernstein; Martina Brueckner; Elizabeth Goldmuntz; Richard W Kim; Richard P Lifton; George A Porter; Martin Tristani-Firouzi; Wendy K Chung; Amy Roberts; Bruce D Gelb; Yufeng Shen; Jane W Newburger
Journal:  Circ Genom Precis Med       Date:  2022-02-07

8.  Proportion of Orofacial Clefts Attributable to Recognized Risk Factors.

Authors:  Janhavi R Raut; Regina M Simeone; Sarah C Tinker; Mark A Canfield; R Sue Day; A J Agopian
Journal:  Cleft Palate Craniofac J       Date:  2018-05-04

9.  Neonatal outcomes in fetuses with cardiac anomalies and the impact of delivery route.

Authors:  Laura I Parikh; Katherine L Grantz; Sara N Iqbal; Chun-Chih Huang; Helain J Landy; Melissa H Fries; Uma M Reddy
Journal:  Am J Obstet Gynecol       Date:  2017-05-31       Impact factor: 8.661

10.  Treatment of Obesity in Patients With Diabetes.

Authors:  Carolyn T Bramante; Clare J Lee; Kimberly A Gudzune
Journal:  Diabetes Spectr       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.